Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsTrendsHealthMerck says its antiviral pill less effective in final analysis

    Merck says its antiviral pill less effective in final analysis

    The lower efficacy is a disappointment for the drug, known as molnupiravir, which health officials around the world are counting on as a critical tool to save lives and reduce the burden on hospitals.

    New York Times
    November 27, 2021 / 09:24 IST
    An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP. (Representative image: Reuters)
    • PRO Panorama

      Moneycontrol Pro Panorama | Liquid cheer for markets, a forecasting lesson for RBI

      Dec 5, 2025 / 02:50 PM IST

      In Moneycontrol's Pro Panorama December 5 edition: RBI's 25 bps rate cut impact on Indian economy, India's structural transformati...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts